2017
DOI: 10.5958/2231-5675.2017.00021.7
|View full text |Cite
|
Sign up to set email alerts
|

Development and Validation of UV Spectrophotometric Method for The Simultaneous Estimation of Rosuvastatin and Ezetimibe in Pharmaceutical Dosage Form

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2019
2019
2025
2025

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 10 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Literature survey found less methods to determine the clopidogrel, aspirin and some are reported for ezetimibe and rosuvastatin [11,12] only. Some authors [13][14][15] reported rosuvastatin and ezetimibe in pharmacokinetic studies. Main objective of this study was to develop a single HPLC method to determine aspirin, rosuvastatin, ezetimibe and clopidogrel in tablets dosage form.…”
mentioning
confidence: 99%
“…Literature survey found less methods to determine the clopidogrel, aspirin and some are reported for ezetimibe and rosuvastatin [11,12] only. Some authors [13][14][15] reported rosuvastatin and ezetimibe in pharmacokinetic studies. Main objective of this study was to develop a single HPLC method to determine aspirin, rosuvastatin, ezetimibe and clopidogrel in tablets dosage form.…”
mentioning
confidence: 99%